Ian Walters
Chief Executive Officer bei PORTAGE BIOTECH INC.
Vermögen: 216 510 $ am 31.03.2024
Profil
Ian B. Walters, Gründer der SalvaRx Group Plc, ist gegenwärtig Chief Executive Officer & Director bei Portage Biotech, Inc. sowie Chief Executive Officer & Director bei iOX Therapeutics Ltd. (eine Tochtergesellschaft von Portage Biotech, Inc.) und Chief Medical Officer & Vice President bei Intensity Therapeutics, Inc. Ian B. Walters ist auch im Vorstand von Enzo Biochem, Inc. und RIFT biotherapeutics, Inc. In seiner früheren Karriere war er Chief Executive Officer der SalvaRx Group Plc, SVP-Translational Medicine & Corporate Development bei Sorrento Therapeutics, Inc. und Mitglied der Bristol-Myers Squibb Canada Co. Er erhielt einen Doktortitel vom Albert Einstein College of Medicine, Inc. und einen MBA von der Wharton School der University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PORTAGE BIOTECH INC
1,25% | 31.03.2023 | 246 516 ( 1,25% ) | 138 789 $ | 31.03.2024 |
ENZO BIOCHEM, INC.
0,12% | 08.12.2023 | 61 198 ( 0,12% ) | 77 721 $ | 31.03.2024 |
Aktive Positionen von Ian Walters
| Unternehmen | Position | Beginn |
|---|---|---|
| PORTAGE BIOTECH INC. | Chief Executive Officer | 06.05.2019 |
| ENZO BIOCHEM, INC. | Director/Board Member | 25.11.2020 |
iOX Therapeutics Ltd.
 iOX Therapeutics Ltd. BiotechnologyHealth Technology iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom. | Director/Board Member | 01.07.2015 |
Stimunity SAS
 Stimunity SAS BiotechnologyHealth Technology Stimunity SAS provides biotechnology services. The company is based in Paris, France. The French company was founded in 2016 by Sylvain Carlioz, Nicolas Manel. Sylvain Carlioz has been the CEO since 2016. | Chairman | - |
SalvaRx Ltd.
 SalvaRx Ltd. BiotechnologyHealth Technology SalvaRx Ltd. develops and provides treatment in the field of cancer immunology. The company is headquartered in London, the United Kingdom. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Ian Walters
| Unternehmen | Position | Ende |
|---|---|---|
| INTENSITY THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.08.2023 |
| SALVARX GROUP PLC | Founder | 08.01.2019 |
Bristol-Myers Squibb Canada Co.
 Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Canada Co. designs, develops and wholesales pharmaceutical products. The company is headquartered in Halifax, Canada. | Chief Operating Officer | 01.03.2014 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Ian Walters
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ENZO BIOCHEM, INC. | Health Technology |
| PORTAGE BIOTECH INC. | Health Technology |
| INTENSITY THERAPEUTICS, INC. | Health Technology |
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
3Legs Resources Plc
 3Legs Resources Plc Financial ConglomeratesFinance 3Legs Resources Plc engages in the provision of investing in acquire companies within the technology sector. It includes interest in a proposed investment and acquisition. The company was founded on July 22, 2002 and is headquartered in Ramsey, Isle of Man. | Finance |
Bristol-Myers Squibb Canada Co.
Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Canada Co. designs, develops and wholesales pharmaceutical products. The company is headquartered in Halifax, Canada. | Health Technology |
SalvaRx Ltd.
SalvaRx Ltd. BiotechnologyHealth Technology SalvaRx Ltd. develops and provides treatment in the field of cancer immunology. The company is headquartered in London, the United Kingdom. | Health Technology |
iOX Therapeutics Ltd.
iOX Therapeutics Ltd. BiotechnologyHealth Technology iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom. | Health Technology |
SalvaRx Group Plc
 SalvaRx Group Plc BiotechnologyHealth Technology SalvaRx Group Plc engages in the development of drug that focuses on cancer immune-oncology. Its products portfolio includes iOx therapeutics, intensity therapeutics, nekonal oncology, and rift biotherapeutics. The company was founded by Ian B. Walters and Robert A. Kramer in 2007 and is headquartered in Ramsey, Isle of Man. | Health Technology |
RIFT biotherapeutics, Inc.
 RIFT biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services RIFT biotherapeutics, Inc. operates as a therapeutic antibody company that focuses on immuno-oncology targets outside of the T-cell space. It generates therapeutic antibodies that harness the immune system, to target cancers in areas of unmet needs. The company was founded by Miguel A. de los Ríos, Cornelia Bentley, and Jeff Pitman in 2015 and is headquartered in San Diego, CA. | Commercial Services |
Stimunity SAS
Stimunity SAS BiotechnologyHealth Technology Stimunity SAS provides biotechnology services. The company is based in Paris, France. The French company was founded in 2016 by Sylvain Carlioz, Nicolas Manel. Sylvain Carlioz has been the CEO since 2016. | Health Technology |
